Complications after bladder augmentation in children.

PURPOSE Bladder augmentation is an effective surgical procedure for increasing bladder capacity and reducing pressure on the urinary system. It is indicated for patients with anomalies such as spina bifida, myelomeningocele, urethral valve and bladder exstrophy, who progress with low tolerance of medication. CASES This was a retrospective study conducted on pediatric patients submitted to bladder augmentation from 2000 to 2011. RESULTS 34 patients aged 4 to 17 years were submitted to bladder augmentation, 30 of them with an ileal loop and 4 with a ureter.A continent urinary shunt was performed in 16 patients, the Mitrofanoff conduit was associated in 15, and the Macedo technique was used in one. Mean follow-up was 34.35 months (1 to 122 months). Mean creatinine was 1.5 ng/ml (0.4 to 7.5 ng/ml) preoperatively and 1.78 ng/ml postoperatively. Three patients required a renal transplant during follow-up. There was improvement or resolution of vesicoureteral reflux in 83.5% of the kidneys on the right and in 75% on the left. Bladder capacity increased, on average, from 152.5 ml to 410 ml. The main complications were vesical lithiasis in 3 patients and conduit perforation in one. CONCLUSION Bladder augmentation showed good results in this series, preserving renal function in most of the patients.

[1]  A. Nagai,et al.  Botulinum toxin type A for the treatment of lower urinary tract disorders , 2012, International journal of urology : official journal of the Japanese Urological Association.

[2]  D. Kehl,et al.  Complications after bladder augmentation or substitution in children: a prospective study of 86 patients , 2011, BJU international.

[3]  R. Subramaniam,et al.  Efficacy of bladder irrigation and surveillance program in prevention of urinary tract infections and bladder calculi in children with an ileocystoplasty and bladder neck repair , 2011, Pediatric Surgery International.

[4]  R. Romero,et al.  Es la inyección de Toxina botulínica-A en el detrusor una alternativa a la ampliación vesical en niños , 2011 .

[5]  A. Parente,et al.  [Injection of botulinum toxin (BTX-A) in children with bladder dysfunction due to detrusor overactivity]. , 2011, Actas urologicas espanolas.

[6]  B. Burgu,et al.  The need for ureteric re‐implantation during augmentation cystoplasty: video‐urodynamic evaluation , 2010, BJU international.

[7]  G. Läckgren,et al.  Pathophysiology of Bladder dysfunction , 2010 .

[8]  M. Duvdevani,et al.  Bladder neck closure in children: a decade of followup. , 2009, The Journal of urology.

[9]  P. Reddy,et al.  Long-term outcomes of the neobladder in pediatric continent urinary reconstruction. , 2009, The Journal of urology.

[10]  G. Karsenty,et al.  Botulinum toxin-A (Botox) intradetrusor injections in children with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic literature review. , 2009, Journal of pediatric urology.

[11]  J. Gearhart,et al.  Mitrofanoff continent catheterizable conduits: top down or bottom up? , 2008, Journal of pediatric urology.

[12]  A. Farkas,et al.  Quality of life: urinary bladder augmentation or substitution in children , 2009, Pediatric Surgery International.

[13]  J. C. Austin Long-term risks of bladder augmentation in pediatric patients , 2008, Current opinion in urology.

[14]  R. Rink,et al.  Reflux in cystoplasties. , 2008, Archivos espanoles de urologia.

[15]  J. M. Viguer,et al.  Enterocystoplasty in children with neuropathic bladders: long-term follow-up. , 2008, Journal of pediatric urology.

[16]  A. Saad,et al.  Augmentation ureterocystoplasty in boys with valve bladder syndrome. , 2007, Journal of pediatric urology.

[17]  O. Mäkitie,et al.  Skeletal health after intestinal bladder augmentation: findings in 54 patients , 2007, BJU international.

[18]  J. Dehoorne,et al.  The effect of botulinum-A toxin in incontinent children with therapy resistant overactive detrusor. , 2006, The Journal of urology.

[19]  K. Miller,et al.  Repeated botulinum-A toxin injections in treatment of children with neurogenic detrusor overactivity. , 2005, Urology.

[20]  E. Cheng,et al.  Ureterocystoplasty: indications for a successful augmentation. , 2004, The Journal of urology.

[21]  T. Michael,et al.  Botulinum-a toxin detrusor injection as a novel approach in the treatment of bladder spasticity in children with neurogenic bladder. , 2003, European urology.

[22]  E. Jaureguizar,et al.  Should we treat vesicoureteral reflux in patients who simultaneously undergo bladder augmentation for neuropathic bladder? , 2001, The Journal of urology.

[23]  M. Srougi,et al.  A continent catheterizable ileum‐based reservoir , 2000, BJU International.

[24]  C. Ackerley,et al.  Stone formation after augmentation cystoplasty: the role of intestinal mucus. , 1997, The Journal of urology.

[25]  P. Nasrallah,et al.  Bladder augmentation in patients with neurogenic bladder and vesicoureteral reflux. , 1991, The Journal of urology.

[26]  P. Mitrofanoff [Trans-appendicular continent cystostomy in the management of the neurogenic bladder]. , 1980, Chirurgie pediatrique.